WHO IRIS >

Consultation par Titre

ou saisir les premières lettres: 
  Limiter les résultats par langue
 
Trier par: Par ordre: Résultats/Page Auteurs/Enregistrement
Résultats 109857 à 109876 sur 127197
PrévisualisationDate de publicationTitreAuteur(s)Numéro de document
23_4_2009.pdf.jpg2009Zanamivir inhalation powder must not be nebulized--
22_2_2008.pdf.jpg2008Zanamivir : neuropsychiatric events--
2011-27 AFRO_DPC - Zanzibar Malaria.pdf.jpgsep-2011Zanzibar Malaria Performance Review Report-2011-27
23-mar-2015Zero infection.Woolhouse, M; Drury, P; Dye, C; Mark Woolhouse is a professor at the Centre for Immunity, Infection & Evolution at the University of Edinburgh, Edinburgh, UK.Patrick Drury is Manager of the Global Outbreak Alert and Response Network of the World Health Organization, Geneva, Switzerland.Christopher Dye is the Director of Strategy in the Office of the Director General at the World Health Organization, Geneva, Switzerland.; Mark Woolhouse is a professor at the Centre for Immunity, Infection & Evolution at the University of Edinburgh, Edinburgh, UK.Patrick Drury is Manager of the Global Outbreak Alert and Response Network of the World Health Organization, Geneva, Switzerland.Christopher Dye is the Director of Strategy in the Office of the Director General at the World Health Organization, Geneva, Switzerland. dyec@who.int.-
1987Zimbabwe : du supermarché à la cafétéria / H. AnendenAnenden, H-
1987Zimbabwe : from supermarket to cafeteria / by H. AnendenAnenden, H-
2011-28 AFRO_DPC - Zimbabwe Malaria.pdf.jpgjui-2011Zimbabwe Malaria Programme Review Report-2011-28
DAP_88.6.pdf.jpg1988Zimbabwe national essential drugs program, ZEDAP : joint WHO/DANIDA mid-term review, 19 April - 3 May 1988 / review mission team, W. C. Chelemu ... [et al.]Chelemu, W. C; Davidson, N. McD; Glistrup, L; Walker, Godfrey J. A; Moore, G. D; World Health Organization. Action Programme on Essential Drugs and Vaccines; DANIDADAP/88.6. Unpublished
WHO_EHC_221.pdf.jpg2001ZincSimon-Hettich, B; Wibbertmann, A; Wagner, D; Tomaska, L; Malcolm, H; World Health Organization; International Programme on Chemical Safety-
23-mar-2015Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: A randomized controlled trial.Habib, MA; Soofi, S; Sheraz, A; Bhatti, ZS; Okayasu, H; Zaidi, SZ; Molodecky, NA; Pallansch, MA; Sutter, RW; Bhutta, ZA; Aga Khan University, Karachi, Pakistan.; WHO, Headquarters, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland.; National Institute of Health (NIH), Islamabad, Pakistan.; Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.; Aga Khan University, Karachi, Pakistan. Electronic address: zulfiqar.bhutta@aku.edu.-
WHO_VBC_DS_87.73.pdf.jpg1987ZiramWorld Health Organization. Division of Vector Biology and ControlWHO/VBC/DS/87.73. Unpublished
WHO_VBC_DS_87.73_fre.pdf.jpg1987ZirameWorld Health Organization. Division of Vector Biology and ControlWHO/VBC/DS/87.73. Unpublished
24_4_2010.pdf.jpg2010Zoledronic acid solution: renal dysfunction--
25_1_2011.pdf.jpg2011Zoledronic acid : withdrawal of application for an extension of indication--
21_1_2007.pdf.jpg2007Zolpidem and bizarre sleep related effects--
21_1_2007_spa.pdf.jpg2007Zolpidem y efectos extraños relacionados con el sueño--
1992Zonas sanitarias menores para mejorar el servicio / M. Abdel Rahim ... [et al.]Abdel Rahim, I. M; Elkaki, B. A; Ali, M. M. A; Elsayd, A. H; Nalder, Susan; Gorosh, Martin-
WHA3_77_fre.pdf.jpg1950Zones de démonstrations sanitaires : Ordre du jour provisoire, point P. 7.1.1.3 : Propositions présentées par la délégation EgyptienneAssemblée mondiale de la Santé, 3A3/77
2003Zonisamide and visual hallucinations : safety issues--
23_2_2009.pdf.jpg2009Zonisamide : metabolic acidosis--
Résultats 109857 à 109876 sur 127197